Pharma stocks are currently seen as a strong investment due to robust earnings potential. Midcap IT stocks are outperforming their largecap counterparts. L&T’s entry into the power equipment sector might increase competition. FMCG sector growth appears slow, but niche categories may offer opportunities. Tier II PSU banks are also showing potential despite higher valuations.
What should investors do with RIL stock? Rahul Sharma answers
Nifty definitely has been difficult in this month given the kind of correction that we have seen. So, we all know the reasons why it